Los Angeles Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.25K Hold
348
– – ﹤0.01% 2119
2026
Q1
$6.67K Hold
348
– – ﹤0.01% 2046
2025
Q4
$5.08K Buy
+348
New +$6.28K ﹤0.01% 2278
2025
Q1
– Sell
-6,205
Closed -$224K – 1222
2024
Q4
$224K Hold
6,205
– – ﹤0.01% 1026
2024
Q3
$263K Buy
+6,205
New +$263K ﹤0.01% 1055
2022
Q2
– Sell
-2,092
Closed -$243K – 1460
2022
Q1
$243K Buy
2,092
+112
+6% +$13.1K ﹤0.01% 1314
2021
Q4
$298K Sell
1,980
-174
-8% -$23.5K ﹤0.01% 1240
2021
Q3
$257K Hold
2,154
– – ﹤0.01% 1355
2021
Q2
$210K Sell
2,154
-138
-6% -$12.3K ﹤0.01% 1486
2021
Q1
$202K Sell
2,292
-315
-12% -$29.3K ﹤0.01% 1540
2020
Q4
$249K Sell
2,607
-775
-23% -$79.9K ﹤0.01% 1427
2020
Q3
$384K Sell
3,382
-3,210
-49% -$337K ﹤0.01% 1190
2020
Q2
$652K Sell
6,592
-21,293
-76% -$1.7M ﹤0.01% 1010
2020
Q1
$1.79M Buy
27,885
+15,055
+117% +$1.05M 0.01% 562
2019
Q4
$765K Buy
12,830
+1,270
+11% +$78.3K ﹤0.01% 907
2019
Q3
$682K Buy
11,560
+7,860
+212% +$502K ﹤0.01% 907
2019
Q2
$239K Sell
3,700
-3,370
-48% -$218K ﹤0.01% 1250
2019
Q1
$449K Buy
+7,070
New +$371K ﹤0.01% 1114
2017
Q2
– Sell
-1,325
Closed -$16K – 1249
2017
Q1
$16K Buy
+1,325
New +$29K ﹤0.01% 1133

Other funds holding TNDM

Los Angeles Capital Management's TNDM Position: Q2 2026 in Review

Los Angeles Capital Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 348 shares worth $5.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

Los Angeles Capital Management first reported a position in TNDM in Q1 2017 and has held it in 19 quarters since. The position peaked at $1.79M in Q1 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Los Angeles Capital Management held 348 shares of Tandem Diabetes Care worth $5.25K as of Q2 2026.
  • Los Angeles Capital Management left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2119 holding.
  • Los Angeles Capital Management first reported a position in Tandem Diabetes Care in Q1 2017 and has held it in 19 quarters since.
  • Los Angeles Capital Management's Tandem Diabetes Care position peaked at $1.79M in Q1 2020.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.